Neuroleptic Treatment of Late-Life Schizophrenia

REFERENCES

• Jeste DV, Eastham JH, Lohr JB, Salzman C. Treatment of dis- ordered behavior and psychosis. In: Salzman C, ed. Clinical geriatric psychopharmacology. 3rd ed. Baltimore: Williams & Wilkins, 1998:106–49.
   Google Scholar
• Elon R, Pawlson LG. The impact of OBRA on medical practice within nursing facilities. J Am Geriatr Soc 1992;40:958–63.
   PubMed Web of Science ®Google Scholar
• Rovner BW, Elelman BA, Cox MP, Shmuely Y. The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry 1992;149:1390–2.
   PubMed Web of Science ®Google Scholar
• Shorr RI, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA 1994;271:358–62.
   PubMed Web of Science ®Google Scholar
• Sweet RA, Pollock BG. Neuroleptics in the elderly: guidelines for monitoring. Harvard Rev Psychiatry 1995;2:327–35.
   Web of Science ®Google Scholar
• Salzman C. Treatment of agitation in the elderly. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:1167–76.
   Google Scholar
• Mulsant BH, Gershon S. Neuroleptics in the treatment of psy- chosis in late life. A rational approach. Int J Geriatr Psychia- try 1993;8:979–92.
   Web of Science ®Google Scholar
• Jeste DV, Eastham JH, Lacro JP, Gierz M, Field MG, Harris MJ. Management of late-life psychosis. J Clin Psychiatry 1996;57(suppl 3):39-45.
   Google Scholar
• Raskind MA, Risse SC. Antipsychotic drugs and the elderly. J Clin Psychiatry 1986;47(suppl):17-22.
   Google Scholar
• Pearlson G, Rabins P. The late-onset psychoses. Possible risk factors. Psychiatr Clin North Am 1988;11:15–32.
   PubMed Web of Science ®Google Scholar
• Castle DJ, Wessley S, Howard R, Murray RM. Schizophrenia with onset at the extremes of adult life. Int J Geriatr Psychia- try 1997;12:712–7.
   PubMed Web of Science ®Google Scholar
• Rabins P, Pauker S, Thomas J. Can schizophrenia begin after age 44? Compr Psychiatry 1984;25:290–3.
   PubMed Web of Science ®Google Scholar
• Pearlson GD, Kreger L, Rabins PV, Chase GA, Cohen B, Wirth JB, et al. A chart review study of late-onset and early-onset schizophrenia. Am J Psychiatry 1989;146:1568–74.
   PubMed Web of Science ®Google Scholar
• Roth M. The natural history of mental disorders in old age. J Ment Sci 1955;101:281–301.
   PubMed Web of Science ®Google Scholar
• Post F. Persistent persecutory state of the elderly. London: Pergamon, 1966.
   Google Scholar
• Herbert ME, Jacobson S. Late paraphrenia. Br J Psychiatry 1967;113:461–9.
   PubMed Web of Science ®Google Scholar
• Holden NL. Late paraphrenia or the paraphrenias? A descrip- tive study with a 10-year follow-up. Br J Psychiatry 1987; 150:635–9.
   PubMedGoogle Scholar
• Howard R, Levy R. Which factors affect treatment response in late paraphrenia? Int J Geriatr Psychiatry 1992;7:667–72.
   Google Scholar
• Andreasen NC. I don’t believe in late onset schizophrenia. In: Howard R, Rabins PV, Castle DJ, eds. Late onset schizophre- nia. Petersfield, UK: Wrightson Biomedical Publishing, 1999: 111–26.
   Google Scholar
• Salzman C, Naidoo U, Schwab E, Czworka K. Elderly patients with schizophrenia. Presented at the 39th annual meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 2000.
   Google Scholar
• Howard R, Rabins PV, Seeman MV, Jeste DV, et al. Consensus statement of the International Late Onset Schizophrenia Group. In: Howard R, Rabins PV, Castle DJ, eds. Late onset schizophrenia. Petersfield, UK: Wrightson Biomedical Pub- lishing, 1999:263–6.
   Google Scholar
• Craig TJ, Bregman Z. Late onset schizophrenia-like illness. J Am Geriatr Soc 1988;36:104–7.
   Google Scholar
• Honigfeld G, Rosenbaum MP, Blumenthal IJ, Lambert HL, Roberts AJ. Behavioral improvement in the older schizo- phrenic patients: drug and social therapies. J Am Geriatr Soc 1965;13:57–71.
   Google Scholar
• McClure FS, Jeste DV. Treatment of late onset schizophrenia and related disorders. In: Howard R, Rabins PV, Castle DJ, eds. Late onset schizophrenia. Petersfield, UK: Wrighton Bio- medical Publishing, 1999:217–32.
   Google Scholar
• Davidson M, Harvey PD, Powchik P, Parnella M, White L, Knobler HY, et al. Severity of symptoms in chronically institu- tionalized geriatric schizophrenia patients. Am J Psychiatry 1995;152:197–207.
   PubMed Web of Science ®Google Scholar
• Jorgensen P, Munk-Jorgensen P. Paranoid psychosis in the el- derly. A follow-up study. Acta Psychiatr Scand 1985;72:358–63.
   PubMed Web of Science ®Google Scholar
• Raskind M, Alvarez C, Herlin S. Fluphenazine enanthate in the outpatient treatment of late paraphrenia. J Am Geriatr Soc 1979;27:459–63.
   Google Scholar
• Tsuang MM, Lu LM, Stotsky BA, Cole JO. Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double- blind study. J Am Geriatr Soc 1971;19:593–600.
   PubMedGoogle Scholar
• Branchey MH, Lee JH, Amin R, Simpson GM. High- and low- potency neuroleptics in elderly psychiatric patients. JAMA 1978;239:1860–62.
   Google Scholar
• Pitner JK, Mintzer JE, Pennypacker LC, Jackson CW. Efficacy and adverse effects of clozapine in four elderly psychotic pa- tients. J Clin Psychiatry 1995;56:180–5.
   Google Scholar
• Salzman C, Vacarro B, Lieff K, Weiner A. Clozapine in older patients with psychosis and behavioral disturbance. Am J Geriatr Psychiatry 1995;3:26–33.
   PubMed Web of Science ®Google Scholar
• Chengappa KN, Baker RW, Kreinbrook SB, Adair D. Cloza- pine use in female geriatric patients with psychoses. J Geriatr Psychiatry Neurol 1995;8:12–5.
   PubMed Web of Science ®Google Scholar
• Howanitz E, Pardo M, Smelson DA, Engelhart C, Eisenstein N, Losonczy MF. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. J Clin Psychiatry 1999;60:41–4.
   PubMed Web of Science ®Google Scholar
• Barak Y, Wittenberg N, Naor S, Kutzuk D, Weizman A. Clo- zapine in elderly psychiatric patients: tolerability, safety, and efficacy. Compr Psychiatry 1999;40:320–5.
   PubMed Web of Science ®Google Scholar
• Frankenburg FR, Kalunian D. Clozapine in the elderly. J Geriatr Psychiatry Neurol 1994;7:129–32.
   Google Scholar
• Madhusoodanan S, Suresh P, Brenner R, Pillai R. Experience with the atypical antipsychotics—risperidone and olanzapine in the elderly. Ann Clin Psychiatry 1999;11:113–8.
   PubMedGoogle Scholar
• Berman I, Merson A, Sison C, Allan E, Schaefer C, Loberboym M, et al. Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pi- lot study. Psychopharmacol Bull 1996;32:95–100.
   Google Scholar
• Lacro JP, Eastham JH, Gilbert PL. Risperidone treatment in old patients with psychosis. In: National Clinical Drug Eval- uation Unit Proceedings, Boca Raton, Florida, May 1996.
   Google Scholar
• Jeste DV, Rockwell E, Harris MJ, Lohr JB, Lacro JP. Conven- tional versus newer antipsychotics in elderly. Am J Geriatr Psychiatr 1999;7:70–6.
   PubMed Web of Science ®Google Scholar
• Borison RL, Davidson M, Berman I. Risperidone treatment in elderly patients with schizophrenia or dementia. Presented at the American Psychiatric Association 46th Institute of Hospi- tal and Community Psychiatry, San Diego, California, Sep- tember-October 1994.
   Google Scholar
• Allen RL, Walker Z, D’Ath PJ, Katona CL. Risperidone for psy- chotic and behavioural symptoms in Lewy body dementia [Letter]. Lancet 1995;346:185.
   PubMed Web of Science ®Google Scholar
• Howard R, Levy R. Charles Bonnet syndrome plus: complex visual hallucinations of Charles Bonnet syndrome type in late paraphrenia. Int J Geriatr Psychiatry 1994;9:399–404.
   Web of Science ®Google Scholar
• Kennedy JS, Basson BR, Zagar AJ, Milton DR, Clark WS, Street JS, et al. The effects of olanzapine on Alzheimer’s dis- ease assessment scale scores in patients with mild to moder- ate Alzheimer’s disease with psychosis and behavioral distur- bances. Presented at the 38th annual meeting of the American College of Neuropsychopharmacology, Acapulco, Mexico, De- cember 1999.
   Google Scholar
• Johnson V, Bruxner G. Neuroleptic malignant syndrome asso- ciated with olanzapine. Aust NZ J Psychiatry 1998;32:884–6.
   PubMed Web of Science ®Google Scholar
• Sajatovic M, Perez D, Brescan D, Ramirez LF. Olanzapine therapy in elderly patients with schizophrenia. Psychophar- macol Bull 1998;34:819–23.
   PubMed Web of Science ®Google Scholar
• Arvantis LA, Miller BG. Multiple fixed doses of “seroquel” (quetiapine) in patients with acute exacerbation of schizophre- nia: a comparison with haloperidol and placebo. Biol Psychia- try 1997;42:233–46.
   PubMed Web of Science ®Google Scholar
• Harvey PD. Cognitive and functional impairments in elderly patients with schizophrenia: a review of the recent literature. Harvard Rev Psychiatry 2001;9:59–68.
   PubMed Web of Science ®Google Scholar